The Sei Foundation is reportedly considering acquiring the biotechnology company 23andMe, with the intention of placing genetic data on the blockchain. This move aims to merge healthcare with blockchain technology to enhance data security and accessibility for users. 23andMe, known for its genetic testing services, faces challenges around data privacy and ownership, which blockchain could potentially address by allowing individuals more control over their personal genetic information. The proposal highlights a growing trend in the blockchain sector, seeking innovative applications beyond financial services. By utilizing blockchain, the Sei Foundation intends to create a secure and transparent method for individuals to manage and share their genetic data, potentially revolutionizing how genetic information is utilized and protected.

Source 🔗